Cargando…
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756038/ https://www.ncbi.nlm.nih.gov/pubmed/30872781 http://dx.doi.org/10.1038/s41375-019-0444-6 |
| _version_ | 1783453338304512000 |
|---|---|
| author | Vendramini, Elena Bomben, Riccardo Pozzo, Federico Benedetti, Dania Bittolo, Tamara Rossi, Francesca Maria Dal Bo, Michele Rabe, Kari G. Pozzato, Gabriele Zaja, Francesco Chiarenza, Annalisa Di Raimondo, Francesco Braggio, Esteban Parikh, Sameer A. Kay, Neil E. Shanafelt, Tait D. Del Poeta, Giovanni Gattei, Valter Zucchetto, Antonella |
| author_facet | Vendramini, Elena Bomben, Riccardo Pozzo, Federico Benedetti, Dania Bittolo, Tamara Rossi, Francesca Maria Dal Bo, Michele Rabe, Kari G. Pozzato, Gabriele Zaja, Francesco Chiarenza, Annalisa Di Raimondo, Francesco Braggio, Esteban Parikh, Sameer A. Kay, Neil E. Shanafelt, Tait D. Del Poeta, Giovanni Gattei, Valter Zucchetto, Antonella |
| author_sort | Vendramini, Elena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6756038 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67560382019-09-24 KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival Vendramini, Elena Bomben, Riccardo Pozzo, Federico Benedetti, Dania Bittolo, Tamara Rossi, Francesca Maria Dal Bo, Michele Rabe, Kari G. Pozzato, Gabriele Zaja, Francesco Chiarenza, Annalisa Di Raimondo, Francesco Braggio, Esteban Parikh, Sameer A. Kay, Neil E. Shanafelt, Tait D. Del Poeta, Giovanni Gattei, Valter Zucchetto, Antonella Leukemia Letter Nature Publishing Group UK 2019-03-14 2019 /pmc/articles/PMC6756038/ /pubmed/30872781 http://dx.doi.org/10.1038/s41375-019-0444-6 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Vendramini, Elena Bomben, Riccardo Pozzo, Federico Benedetti, Dania Bittolo, Tamara Rossi, Francesca Maria Dal Bo, Michele Rabe, Kari G. Pozzato, Gabriele Zaja, Francesco Chiarenza, Annalisa Di Raimondo, Francesco Braggio, Esteban Parikh, Sameer A. Kay, Neil E. Shanafelt, Tait D. Del Poeta, Giovanni Gattei, Valter Zucchetto, Antonella KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival |
| title | KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival |
| title_full | KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival |
| title_fullStr | KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival |
| title_full_unstemmed | KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival |
| title_short | KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival |
| title_sort | kras, nras, and braf mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756038/ https://www.ncbi.nlm.nih.gov/pubmed/30872781 http://dx.doi.org/10.1038/s41375-019-0444-6 |
| work_keys_str_mv | AT vendraminielena krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT bombenriccardo krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT pozzofederico krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT benedettidania krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT bittolotamara krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT rossifrancescamaria krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT dalbomichele krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT rabekarig krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT pozzatogabriele krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT zajafrancesco krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT chiarenzaannalisa krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT diraimondofrancesco krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT braggioesteban krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT parikhsameera krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT kayneile krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT shanafelttaitd krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT delpoetagiovanni krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT gatteivalter krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival AT zucchettoantonella krasnrasandbrafmutationsarehighlyenrichedintrisomy12chroniclymphocyticleukemiaandareassociatedwithshortertreatmentfreesurvival |